Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Begbies buys finance broker; Amino Tech makes US bid

Mon, 10th May 2021 13:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Mincon Group PLC - Shannon, Ireland-based engineering firm - Seeing "good order levels" in most markets and says revenue is higher annually in first four months of 2021. "Sea freight lead times remain challenging due to the pandemic, and we are using air freight where necessary to overcome these freight challenges. We curtailed other overheads to compensate for any increased freight costs," Mincon adds. Says manufacturing has recovered with production levels now ahead of 2020, despite Covid-19 hit in early part of 2021.

----------

Begbies Traynor Group PLC - Manchester-based corporate restructuring specialist - Buys Midlands-based finance broker MAF Property Ltd, or MAF Finance Group, for initial GBP3.0 million. Says GBP2.0 million of initial sum to be paid in cash, remainder in shares. Notes potential earn out of up to GBP8.8 million, contingent on "material growth in profits over the four years post completion". "Finance broking complements the group's existing services and deepens relationships with banks and other lenders," Begbies explains.

----------

TP Group PLC - Farnborough, Hampshire-based consulting, digital solutions and engineering services provider - Awarded deal with UK Ministry of Defence worth GBP1.1 million. Will provide consulting and digital services. "TP Group will be working on the MOD's GBP3.2 billion Morpheus Programme to scope the next generation of applications that will be used by military personnel deployed around the world to exploit information faster and enable better decision making," company says. "This contract win is not material in the context of the financial performance of the group."

----------

Duke Royalty Ltd - London-based provider of alternative capital solutions to businesses in Europe - Says cash revenue in fourth quarter ended March 31 totals GBP2.5 million, in line with expectations. "This represented a small like-for-like increase from the previous quarter once the positive effects of redemptions premiums are removed," Duke says. Expects to report first quarter cash revenue of GBP2.8 million.

----------

Amino Technologies PLC - Cambridge, England-based media technology - May acquire MobiTV Inc and MobiTV Services Corp. MobiTV is a US television platform provider that is currently in Chapter 11 bankruptcy. Amino has submitted an acquisition bid to bankruptcy court in the US. "Whether Amino's bid is successful will be decided by the court following an auction process to be held on 11 May 2021," company adds. Says deal would be funded by existing cash and credit resources, bolstered by an equity raise.

----------

Water Intelligence PLC - London-based provider of precision, minimally invasive leak detection and remediation solutions - Seals third insurance national account win of year. "The company's latest business-to-business account reinforces the sustainability of Water Intelligence's growth trajectory for its insurance channel," company adds. Executive Chair Patrick DeSouza adds company is looking to "capture more and more of the USD13 billion insurance market for water-related claims".

----------

Gresham Technologies PLC - London-based financial software and services for data integrity, banking integration, payments, and cash management- Says year "has started well" amid promising demand for its Clareti software platform. "Five new Clareti customers have been signed so far this year, as well as several incremental licences with existing customers," Chair Peter Simmonds says.

----------

Open Orphan PLC - London-based pharmaceutical services company - Lands GBP3.0 million deal with Imperial College London to develop SARS-CoV-2 challenge virus. Says challenge virus will be based on emerging variants of Covid-19. Will be used by Open Orphan's hVIVO "to allow direct comparisons of vaccines or antivirals against different Covid-19 variants".

----------

Dekel Agri-Vision PLC - West Africa-focused agriculture company - Says crude palm oil output down 16% annually in April to 5,147 tonnes. Year-to-date output up 12% to 20,474 tonnes. "April production below last year's volumes due to lower deliveries of fresh fruit bunches," Dekel says. April sales down 2.6% year-on-year to 4,971 tonnes, but year-to-date up 17% to 18,892 tonnes.

----------

Gem Diamonds Ltd - Letseng diamond mine in Lesotho - Recovers "high quality" 370-carat white diamond from Letseng mine in Lesotho.

----------

Castillo Copper Ltd - base metal explorer focused on Australia and Zambia - Gets approval from landowner to recommence exploration work at Mount Oxide project, now that rain season in Queensland, Australia has ended. "Our first priority is to extend known mineralisation discovered at the Big One Deposit. Currently, a team is at site conducting a geophysical survey along the line of lode. Once the geophysical results are interpreted and new targets formulated, our drilling team will complete the remainder of the campaign that was designed in late 2020," Managing Director Simon Paull says. "The board remains optimistic that 2021 will be a transformative year as we ramp up our exploration efforts at the Mt Oxide project, coupled with working towards successfully optimising our Zambia and New South Wales assets."

----------

Cadence Minerals PLC - UK-based mineral resources investor - Says Dev Mineracao SA ships and sells second batch of iron ore from stockpiles at Amapa project, Brazil. Says buyer is "one of the world's largest globally diversified natural resource companies and a major producer and marketer of commodities".

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2022 11:45

Open Orphan's hVIVO wins GBP14.7 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said it's subsidiary hVIVO signed a GBP14.7 million contract for an influenza characterisation study and a follow on influenza human challenge study.

Read more
31 May 2022 16:05

UK earnings, trading statements calendar - next 7 days

Wednesday 1 June  
Impax Asset Management Group PLCHalf Year Results
Dr Martens PLCFull Year Results
Thursday 2 June  
no events scheduled 
Friday  3 June  
no events scheduled  
Monday 6 June  
Atrato Onsite Energy PLCHalf Year Results
Empiric Student Property PLCTrading Statement
Jadestone Energy PLCFull Year Results
Tuesday 7 June  
Gooch & Housego PLCHalf Year Results
LXi REIT PLCFull Year Results
NewRiver REIT PLCFull Year Results
Open Orphan PLCFull Year Results
Schroder Real Estate Investment Trust LtdFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 May 2022 16:43

Open Orphan's hVIVO wins GBP7.3 million influenza study contract

(Alliance News) - Open Orphan PLC on Wednesday said its subsidiary hVIVO Ltd has signed a GBP7.3 million contract.

Read more
18 May 2022 15:15

Open Orphan wins £7.3m human flu study contract

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Wednesday that its hVIVO subsidiary has signed a £7.3m flu human challenge study contract with an unnamed biotechnology company, to test its antiviral product using hVIVO's influenza human challenge study model.

Read more
6 May 2022 19:11

TRADING UPDATES: Enwell pleased with SV-31; SDX Energy ties in well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 May 2022 14:53

IN BRIEF: Open Oprhan wins contract for vaccine field site study

Open Orphan PLC - London-based pharmaceutical services - Subsidiary hVIVO is awarded new study with existing unnamed pharmacetical client to act as vaccination site for the client's respiratory syncytial virus vaccine candidate. hVIVO's specialist arm FluCamp will recruit 60 healthy volunteers to the new site clinic at Plumbers Row where trials will take place.

Read more
13 Apr 2022 19:46

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
1 Apr 2022 20:23

IN BRIEF: Open Orphan Covid study results published in Nature Medicine

Open Orphan PLC - London-based pharmaceutical services - Says Thursday that results from the world's first Covid-19 characterisation study have been peer reviewed and published in the scientific journal Nature Medicine. Says study showed the SARS-CoV-2 human challenge was safe in healthy young adults and provided insights into the course of Covid-19 infection with potential positive public health implications. With the characterisation study disease modelling data completed, and human challenge model established, Open Orphan says it should be able to conduct Covid-19 human challenge studies in 2022.

Read more
25 Mar 2022 14:10

IN BRIEF: Open Orphan wins GBP5 million human challenge study pact

Open Orphan PLC - London-based pharmaceutical services firm - Says its subsidiary, hVIVO, wins contract with a European biotechnology company for a human challenge study. The GBP5 million contract with a European biotech seeks to test hVIVO's intravenous antiviral candidate. The study on the respiratory syncytial virus is expected to commence this year. Revenue from the deal will be recognised across 2022 and 2023.

Read more
25 Mar 2022 09:39

Open Orphan wins £5m contract for human study in RSV

(Sharecast News) - Open Orphan announced on Friday that its hVIVO subsidiary has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with an unnamed European biotechnology company, to test its intravenous antiviral candidate.

Read more
8 Mar 2022 19:37

IN BRIEF: Open Orphan expects to report profitable 2021 performance

Open Orphan PLC - London-based pharmaceutical services - For 2021, expects to report earnings before interest, tax, depreciation and amortisation, on revenue which is set to be GBP40 million, up from GBP20.6 million in 2020. For 2022, the company is targeting GBP50 million in non-Covid work revenue.

Read more
24 Feb 2022 15:24

Open Orphan appoints Mo Khan as its new chief executive

(Sharecast News) - Contract research organisation Open Orphan announced the appointment of Yamin 'Mo' Khan as its chief executive officer on Thursday, with immediate effect.

Read more
24 Feb 2022 14:48

IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to chief executive officer, effective immediately. Khan had joined the Open Orphan board back in October. The company notes he has 25 years of clinical research experience. Cathal Friel remains executive chair, while Open Orphan will aim to find a new independent non-executive director within the next six months.

Read more
22 Feb 2022 21:57

TRADING UPDATES: Angling Direct ups revenue; Ceiba takes Omicron hit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
17 Feb 2022 20:13

IN BRIEF: Positive results from Open Orphan human challenge study

Open Orphan PLC - pharmaceutical services provider - Sees positive results from a human challenge study assessing its respiratory syncytial virus antiviral candidate, EDP-938. Says results from the study have been published in The New England Journal of Medicine. hVIVO, a subsidiary of Open Orphan, conducted the Phase 2a, double-blind, placebo-controlled trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.